Related Topics News -

     
 Title only   |   Print    Next page > 
     
《業績》友芝友生物製藥中期虧損收窄至626萬人民幣

2026-08-28T  
友芝友生物M701治療惡性腹水新藥上市申請獲受理

2026-05-07T  
友芝友生物核心產品M701兩項研究成果入選2026年ASCO年會

2026-04-23T  
友芝友生物完成H股全流通

2026-03-30T  
《業績》友芝友生物全年虧損收窄至8,473.2萬元人民幣

2026-03-30T  
友芝友生物注射用M701臨床試驗獲美FDA批准

2026-02-03T  
友芝友生物作價3,688萬人民幣出售武漢工業地

2026-01-25T  
友芝友生物生物類似藥Y225臨床試驗申請獲批

2025-12-28T  
友芝友生物M701惡性腹水臨床價值獲認可

2025-12-02T  
友芝友生物M 701研究數據在2025年ESMO會議公布

2025-10-19T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.